In vitro effects of undifferentiated callus extracts from Plantago major L, Rhodiola rosea L and Silybum marianum L in normal and malignant human skin cells

Anette Gjörloff Wingren; Riyam Ziyad Faik; Anna Holefors; Edina Filecovic; Anna Gustafsson

doi:10.1016/j.heliyon.2023.e16480

In vitro effects of undifferentiated callus extracts from Plantago major L, Rhodiola rosea L and Silybum marianum L in normal and malignant human skin cells

Heliyon. 2023 May 24;9(6):e16480. doi: 10.1016/j.heliyon.2023.e16480. eCollection 2023 Jun.

Authors

Anette Gjörloff Wingren^{1

2}, Riyam Ziyad Faik^{1

2}, Anna Holefors³, Edina Filecovic^{1

2}, Anna Gustafsson^{1

2}

Affiliations

¹ Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
² Biofilms - Research Center for Biointerfaces, Malmö University, Malmö, Sweden.
³ In Vitro Plant-Tech AB, Geijersg 4B, 21618 Limhamn, Sweden.

Abstract

Background and objectives: The occurrence of non-melanoma and melanoma skin cancers is currently increasing rapidly with one in every three cancers diagnosed as a skin cancer. A useful strategy to control the progression of skin cancer could be the use of plant flavonoids that suppress pro-inflammatory cytokines involved in tumor initiation and progression. In this study, the anti-inflammatory and antioxidant activity of undifferentiated callus extracts from Plantago major L, Silybum marianum L and Rhodiola rosea L was investigated both in normal and malignant skin cells.

Methods: Antioxidant activity of the extracts was analyzed by using the Trolox Equivalent Antioxidant Capacity (TEAC) assay. High-Performance Thin-Layer Chromatography (HPTLC) was performed to demonstrate the phytochemical profile, and the total flavonoid content was analyzed with an aluminum chloride colorimetric method. The anti-inflammatory effect was investigated by cell treatments using the plant extracts. Thereafter, the possible suppression of induced IL-6 response was measured from the cultured skin cancer cell lines A2058 and A431, and normal primary keratinocytes with Enzyme-Linked Immunosorbent Assay (ELISA).

Results: The HPTLC analysis assessed that the extracts contained a complex phytochemical profile that was rich in phenolic and flavonoid compounds. Dose response assays showed that concentrations between 15 and 125 μg/mL of all three plant extracts could be used to investigate an effect on the IL-6 production. The S. marianum extract had the most pronounced anti-inflammatory effect, which significantly inhibited induced IL-6 production in both normal keratinocytes and skin cells derived from epidermal carcinoma. The extract from S. marianum also had the highest flavonoid content and showed the highest antioxidant activity of the three extracts tested.

Conclusion: All in all, we have confirmed that undifferentiated callus extracts of S. marianum possess properties such as antioxidant and anti-inflammatory activities in both normal and malignant keratinocytes, and thus could be a promising agent controlling the pro-inflammatory IL-6 production.

Keywords: Anti-inflammatory; Antioxidant; Flavonoid; HPTLC; Interleukin-6; Keratinocytes; Plantago major L; Trolox; Undifferentiated callus extracts.